Back to today’s briefing

Story perspectives

Western Pharma Giants Partner with China Amid Challenges

2/17/2025

50 9

Summary

Story summary

Western pharmaceutical companies are forging alliances with Chinese firms as they face expiring patents and a staggering $140 billion sales loss projected by 2030. China's biotech industry is booming, fueled by regulatory changes and a vast market. Yet, looming funding challenges and escalating U.S.-China tensions threaten to derail this promising growth and collaboration.

1 of 1

Story summary

Western pharmaceutical companies are forging alliances with Chinese firms as they face expiring patents and a staggering $140 billion sales loss projected by 2030. China's biotech industry is booming, fueled by regulatory changes and a vast market. Yet, looming funding challenges and escalating U.S.-China tensions threaten to derail this promising growth and collaboration.